PMV Pharma IPO

PMV is a biotechnology company dedicated to selectively targeting mutant p53, providing unique therapies for any patient whose tumor harbors these gene mutations.

Register for Details

For more details on financing and valuation for PMV Pharma, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

What is PMV Pharma's ticker symbol?


What is PMV Pharma's stock price?

4.86 as of 3/28/23

Learn more about PMV Pharma

Forge green plus iconForge green minus icon

What is PMV Pharma funding to date?

PMV Pharma has raised $170.8MM.
Forge green plus iconForge green minus icon

When was PMV Pharma founded?

PMV Pharma was founded in 2013.